echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medicines Company News > CRO track all-line surge Tag Pharmaceuticals, Kanglong into a 10% rise in the rise and stop of new drugs

    CRO track all-line surge Tag Pharmaceuticals, Kanglong into a 10% rise in the rise and stop of new drugs

    • Last Update: 2021-01-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    On the morning of January 20, the opening of the pharmaceutical stocks CRO track, Tag pharma, Kanglong into a 10% rise, drug Mingkangde rose nearly 7%, Zhao Yan new drugs rose and stopped.
    from the wave of innovative drugs and the global pharmaceutical research and development outsourcing industry chain to gather in China, CRO track in recent years continued the high business climate.
    Contract Research Organization, or contract research organization, is an academic or commercial scientific institution or individual that conducts all or part of a customer's scientific or medical experiments in the course of drug development for commercial gain.
    CRO industry as an emerging industry, originated in the United States in the 1970s, the early CRO companies in the form of public or private research institutions, small, only for pharmaceutical companies to provide limited drug analysis services.
    beginning in the 1980s, as the FDA's drug regulations continued to improve, the drug development process became more complex, and more and more pharmaceutical companies began to transfer some of their work to CRO companies, and the CRO industry entered its innate years.
    CRO can help pharmaceutical companies reduce research and development costs, reduce research and development risk and improve research and development efficiency, so that the entire pharmaceutical sector to achieve social division of labor specialization, risk averaging.
    CRO enterprises are divided into preclinical CRO and clinical trial CRO two major categories, the current preclinical CRO is mainly engaged in compound research services and preclinical research services, including research, pilot compounds and active drug intermediate synthesis and process development, domestic and foreign companies are mainly Charles River, Covance (has been acquired by LabCorp), Syneos, Pharmaceutical Mingkangde (Apptec), Zhao yanxin pharmaceutical (Joinn Lab), Kanglong.
    preclinical research services include pharmacodynamics, pharmacological toxicology, animal models, etc.
    clinical trial CRO focuses on clinical research services, including phase I to IV clinical trial technical services, clinical trial data management and statistical analysis, registration declaration and post-market drug safety monitoring, domestic and foreign companies are mainly Quintiles IMS (renamed IQVIA, Chinese Kuntai), Covance (acquired by LabCorp), ICON PLC, PAREX PAREL ,PRA Health, TigerMed, Boji Pharmaceuticals, etc.
    : Blue Dot Finance: Global CRO Industry Analysis and Outlook
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.